These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26751348)

  • 1. Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: Part I gram positive bacteria.
    Linder KE; Nicolau DP; Nailor MD
    Expert Opin Drug Metab Toxicol; 2016; 12(3):267-80. PubMed ID: 26751348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: part II Gram-negative bacteria.
    Abdelraouf K; Linder KE; Nailor MD; Nicolau DP
    Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):705-714. PubMed ID: 28486001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving resistance among Gram-positive pathogens.
    Munita JM; Bayer AS; Arias CA
    Clin Infect Dis; 2015 Sep; 61 Suppl 2(Suppl 2):S48-57. PubMed ID: 26316558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Update of antimicrobial resistance in Gram-positive microorganisms].
    Cercenado E
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing antimicrobial therapy for gram-positive bloodstream infections in patients on hemodialysis.
    Pai AB; Pai MP
    Adv Chronic Kidney Dis; 2006 Jul; 13(3):259-70. PubMed ID: 16815231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].
    Loza E; Morosini MI; Pascual A; Tubau F; Alcalá J; Liñares J; Hernández-Bello JR; Baquero F; Perea E; Martín R; Jones RN; Cantón R;
    Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):489-94. PubMed ID: 19094861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme, 2000.
    McDonald LC; Lauderdale TL; Shiau YR; Chen PC; Lai JF; Wang HY; Ho M;
    Int J Antimicrob Agents; 2004 Apr; 23(4):362-70. PubMed ID: 15081085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Daptomycin in the context of antimicrobial resistance in Gram-positive bacteria].
    Candel González FJ
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():10-6. PubMed ID: 22541970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship.
    Aitken SL; Hemmige VS; Koo HL; Vuong NN; Lasco TM; Garey KW
    Diagn Microbiol Infect Dis; 2015 Jan; 81(1):4-8. PubMed ID: 25445120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenotypic detection of resistance mechanisms in gram-positive bacteria].
    Morosini MI; Cercenado E; Ardanuy C; Torres C
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):325-32. PubMed ID: 22130574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and prospective treatments for multidrug-resistant gram-positive infections.
    Rybak JM; Barber KE; Rybak MJ
    Expert Opin Pharmacother; 2013 Oct; 14(14):1919-32. PubMed ID: 23876168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which antibiotic for resistant Gram-positives, and why?
    Bradley JS
    J Infect; 2014 Jan; 68 Suppl 1():S63-75. PubMed ID: 24188585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gram-positive bacterial infections resistant to antibiotic treatment].
    Utili R
    Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010).
    Zhao C; Sun H; Wang H; Liu Y; Hu B; Yu Y; Sun Z; Chu Y; Cao B; Liao K; Lei J; Hu Z; Zhang L; Zhang X; Xu Y; Wang Z; Chen M
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):174-81. PubMed ID: 22521693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of glycopeptide resistance in gram-positive pathogens.
    Courvalin P
    Int J Med Microbiol; 2005 Mar; 294(8):479-86. PubMed ID: 15790292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria.
    Appelbaum PC; Jacobs MR
    Curr Opin Microbiol; 2005 Oct; 8(5):510-7. PubMed ID: 16098786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
    Streit JM; Jones RN; Sader HS; Fritsche TR
    Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
    Dowzicky MJ
    Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.